The current valuation score of Ligand Pharmaceuticals Inc is 6.73, ranking 146 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is 39.17, which is 123.11% below the recent high of 87.38 and 1515.68% above the recent low of -554.46.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.